Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bio-Curcumin is a branded **dietary supplement ingredient/formulation** based on curcumin from *Curcuma longa* and positioned as a high-bioavailability turmeric extract rather than as an approved pharmaceutical drug. Commercial descriptions indicate it is a proprietary curcumin formulation standardized around curcuminoids and combined with turmeric essential oils and, in some marketed versions, phospholipid-based absorption technology to improve oral bioavailability relative to conventional curcumin. Its intended use is wellness support, especially for inflammation, joint health, antioxidant support, and general nutraceutical applications. Mechanistically, curcumin is a pleiotropic small-molecule polyphenol with broad reported effects on inflammatory and oxidative-stress signaling pathways such as nuclear factor kappa-light-chain-enhancer of activated B cells and cyclooxygenase-related pathways, but Bio-Curcumin itself is not an approved drug with a single validated regulatory mechanism of action.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Bio-Curcumin.